GRDN

Profile

Full Name

Guardian Pharmacy Services, Inc.

Ticker Symbol

GRDN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 21, 2016

Indexes

Not included

Website

http://guardianpharmacy.com

Employees

3400

Key Details

Price

$23.52(+0.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.23B(+17.42% YoY)

Annual EPS

-$1.77(-100.00% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.52
GRDN price is $23.52

30-Day Relative Volume

0.66
GRDN 30-day relative volume is 0.66

Price Performance

Price Most recent change

+0.86%
GRDN price was up +0.86% on Apr 16, 2025

Price YTD change

+16.09%
GRDN price is up +16.09% since January 1st

Price 1-year change

-
GRDN price 1-year change is unknown

Price 3-year change

-
GRDN price 3-year change is unknown

Price Range

Price All-time high

$25.73
GRDN price is currently -8.61% below its historical high of $25.73

Price 3-year low

$14.16
GRDN price is currently +66.10% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.49B
GRDN market capitalization is $1.49 billion

Market cap 3-year change

-
GRDN market capitalization 3-year change is unknown

Market cap All-time high

$1.59B
GRDN market capitalization is currently -6.57% below its historical high of $1.59 billion

Market cap sector rank

80.59%
GRDN market capitalization is higher than 80.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
GRDN shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
GRDN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
GRDN beta is 0.62

200-day SMA

$20.62
GRDN price is currently +14.07% above its 200-day simple moving average

50-day SMA

$20.59
GRDN price is currently +14.21% above its 50-day simple moving average

RSI

66.70
GRDN 14-day relative strength index is 66.70

Volume

0.66
GRDN 30-day relative volume is 0.66

ATR

$1.45
GRDN average true range is $1.45

10-day Historical Volatility

39.77%
GRDN 10-day historical volatility is 39.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.23B
GRDN annual revenue is $1.23 billion

Revenue Analysts estimate

$1.34B
GRDN annual revenue is currently -8.40% lower than the consensus analysts' forecast

Revenue 1-year change

+17.42%
GRDN annual revenue is up +17.42% year-on-year

Revenue Sector rank

82.12%
GRDN annual revenue is higher than 82.12% of companies in Healthcare sector

EPS

EPS

-$1.77
GRDN annual earnings per share is -$1.77

EPS Analysts estimate

$0.94
GRDN annual earnings per share is currently -288.30% lower than the consensus analysts' forecast

EPS 1-year change

-100%
GRDN annual earnings per share is down -100% year-on-year

EPS Sector rank

40.76%
GRDN annual earnings per share is higher than 40.76% of companies in Healthcare sector

Profit

Gross profit

$244.37M
GRDN annual gross profit is $244.37 million

Gross margin

19.89%
GRDN annual gross profit margin is 19.89%

Operating profit

-$62.92M
GRDN annual operating income is -$62.92 million

Operating margin

-5.12%
GRDN annual operating profit margin is -5.12%

Net income

-$87.29M
GRDN annual net profit is -$87.29 million

Net margin

-7.11%
GRDN annual net profit margin is -7.11%

Expenses

Total expenses

$1.29B
GRDN annual total expenses is $1.29 billion

Operating expenses

$307.29M
GRDN annual total operating expenses is $307.29 million

Cost of goods sold

$984.04M
GRDN annual cost of goods sold is $984.04 million

Selling, general & administrative expenses

$307.29M
GRDN annual SGA is $307.29 million

Depreciation and amortization

$19.77M
GRDN annual depreciation & amortization is $19.77 million

Interest expense

$3.28M
GRDN annual interest expense is $3.28 million

Income tax

$4.56M
GRDN annual income tax is $4.56 million

EBIT & EBITDA

EBIT

-$63.20M
GRDN annual earnings before interest & taxes is -$63.20 million

EBITDA

-$43.43M
GRDN annual EBITDA is -$43.43 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$320.81M
GRDN annual total assets is $320.81 million

Non current assets

$168.82M
GRDN annual long term assets is $168.82 million

Current assets

$151.99M
GRDN annual total current assets is $151.99 million

Cash and cash equivalents

$4.66M
GRDN annual cash & cash equivalents is $4.66 million

Accounts receivable

$97.15M
GRDN annual accounts receivable is $97.15 million

Inventory

$40.55M
GRDN annual inventory is $40.55 million

Liabilities

Total liabilities

$170.83M
GRDN annual total liabilities is $170.83 million

Long term liabilities

$26.71M
GRDN annual total long term liabilities is $26.71 million

Current liabilities

$144.12M
GRDN annual total current liabilities is $144.12 million

Accounts payable

$102.42M
GRDN annual accounts payable is $102.42 million

Debt

Total debt

$30.13M
GRDN annual total debt is $30.13 million

Total debt 1-year change

-50.6%
GRDN annual total debt is down -50.6% year-on-year

Long term debt

$23.30M
GRDN annual long term debt is $23.30 million

Short term debt

$6.84M
GRDN annual short term debt is $6.84 million

Equity & Capital

Shareholders equity

$142.67M
GRDN annual stockholders equity is $142.67 million

Book value

$142.67M
GRDN annual book value is $142.67 million

Retained earnings

$17.12M
GRDN annual retained earnings is $17.12 million

Working capital

$7.86M
GRDN annual working capital is $7.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$57.96M
GRDN annual cash flow from operations is $57.96 million

Cash from operations 1-year change

-18.16%
GRDN annual cash flow from operations is down -18.16% year-on-year

Cash from investing

-$30.41M
GRDN annual cash flow from investing activities is -$30.41 million

Cash from investing 1-year change

-126.23%
GRDN annual cash flow from investing activities is down -126.23% year-on-year

Cash from financing

-$23.64M
GRDN annual cash flow from financing activities is -$23.64 million

Cash from financing 1-year change

+58.69%
GRDN annual cash flow from financing activities is up +58.69% year-on-year

CAPEX

CAPEX

$16.37M
GRDN annual capital expenditures is $16.37 million

CAPEX 1-year change

+12.45%
GRDN annual capital expenditures is up +12.45% year-on-year

Free Cash Flow

Free cash flow

$41.59M
GRDN annual free cash flow is $41.59 million

Free cash flow 1-year change

-26.08%
GRDN annual free cash flow is down -26.08% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

19.89%
GRDN annual gross profit margin is 19.89%

Operating margin

-5.12%
GRDN annual operating profit margin is -5.12%

Net margin

-7.11%
GRDN annual net profit margin is -7.11%

ROA & ROE

ROA

-29.49%
GRDN annual return on assets is -29.49%

ROE

-83.20%
GRDN annual return on equity is -83.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GRDN price to earnings ratio value is unknown

PE ratio Sector rank

-
GRDN price to earnings ratio is unknown

PB Ratio

PB ratio

10.43
GRDN price to book ratio is 10.43

PB ratio Sector rank

93.17%
GRDN price to book ratio is higher than 93.17% of companies in Healthcare sector

PS Ratio

PS ratio

1.56
GRDN price to sales ratio is 1.56

PS ratio Sector rank

37.31%
GRDN price to sales ratio is higher than 37.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.51B
GRDN enterprise value is $1.51 billion

Enterprise value Sector rank

79.16%
GRDN enterprise value is higher than 79.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-24.86
GRDN EV/EBITDA is -24.86

EV/EBITDA Sector rank

4.96%
GRDN EV/EBITDA is higher than 4.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.05
GRDN annual current ratio is 1.05

Quick ratio

0.77
GRDN annual quick ratio is 0.77

Leverage

Debt to equity

0.00
GRDN annual debt to equity ratio is 0.00

Interest coverage ratio

-19.28
GRDN annual interest coverage ratio is -19.28

Risk & Stability

Piotroski F-Score

-
GRDN piotroski f-score value is unknown

Altman Z-Score

8.51
GRDN altman z-score is 8.51

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Buy
Nov 15, 24 Truist Securities
Buy
Oct 22, 24 Stephens & Co.
Overweight
Oct 21, 24 Truist Securities
Buy

Institutional Ownership

Similar stocks

KNSA logo
Kiniksa Pharmaceuticals (KNSA)
CNMD logo
CONMED (CNMD)
ANIP logo
ANI Pharmaceuticals (ANIP)
ASTH logo
Astrana Health (ASTH)
ATEC logo
Alphatec Holdings (ATEC)
BCRX logo
BioCryst Pharmaceuticals (BCRX)
ARS Pharmaceuticals (SPRY)
OMCL logo
Omnicell (OMCL)
ARQT logo
Arcutis Biotherapeutics (ARQT)
  • What is the ticker symbol for Guardian Pharmacy Services?
  • Does Guardian Pharmacy Services pay dividends?
  • What sector is Guardian Pharmacy Services in?
  • What industry is Guardian Pharmacy Services in?
  • What country is Guardian Pharmacy Services based in?
  • When did Guardian Pharmacy Services go public?
  • Is Guardian Pharmacy Services in the S&P 500?
  • Is Guardian Pharmacy Services in the NASDAQ 100?
  • Is Guardian Pharmacy Services in the Dow Jones?
  • When was Guardian Pharmacy Services's last earnings report?
  • When does Guardian Pharmacy Services report earnings?
  • Should I buy Guardian Pharmacy Services stock now?

What is the ticker symbol for Guardian Pharmacy Services?

The ticker symbol for Guardian Pharmacy Services is NYSE:GRDN

Does Guardian Pharmacy Services pay dividends?

No, Guardian Pharmacy Services does not pay dividends

What sector is Guardian Pharmacy Services in?

Guardian Pharmacy Services is in the Healthcare sector

What industry is Guardian Pharmacy Services in?

Guardian Pharmacy Services is in the Medical Care Facilities industry

What country is Guardian Pharmacy Services based in?

Guardian Pharmacy Services is headquartered in United States

When did Guardian Pharmacy Services go public?

Guardian Pharmacy Services's initial public offering (IPO) was on April 21, 2016

Is Guardian Pharmacy Services in the S&P 500?

No, Guardian Pharmacy Services is not included in the S&P 500 index

Is Guardian Pharmacy Services in the NASDAQ 100?

No, Guardian Pharmacy Services is not included in the NASDAQ 100 index

Is Guardian Pharmacy Services in the Dow Jones?

No, Guardian Pharmacy Services is not included in the Dow Jones index

When was Guardian Pharmacy Services's last earnings report?

Guardian Pharmacy Services's most recent earnings report was on Mar 26, 2025

When does Guardian Pharmacy Services report earnings?

The next expected earnings date for Guardian Pharmacy Services is May 30, 2025

Should I buy Guardian Pharmacy Services stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page